![]() |
The NelsonHall 2025 Global EOR Services NEAT Evaluation highlights G-P as an industry leader in technology innovation and its commitment to offering comprehensive, AI-powered global employment solutions
BOSTON, Sept. 17, 2025 /PRNewswire/ — G-P (Globalization Partners), recognized as the undisputed leader in global employment by industry analysts, today announced its recognition as an EOR industry leader in NelsonHall’s 2025 Global EOR Services NEAT evaluation report. G-P was positioned highest for EOR Product Innovation as well as Overall EOR Services, underscoring its commitment to delivering comprehensive, AI-powered global employment solutions.
G_P named an EOR industry leader in NelsonHall’s 2025 Global EOR Services NEAT evaluation report for EOR Product Innovation as well as Overall EOR Services.
With this recognition, G-P maintains top leadership placement in all major EOR analyst reports since their inception.
“G-P was identified as a Leader in the 2025 Global EOR NEAT based on its innovative GenAI solutions, continuously evolving product lineup, and strong strategic partner network,” said Jeanine Crane-Thompson, principal HR analyst, NelsonHall. “This demonstrates G-P’s commitment to compliant global employment solutions and helping shape the industry’s future through a balanced portfolio of integrated products and a solid technology roadmap.”
G-P’s consistent recognition as a leader for EOR Product Innovation highlights its dedication to advancing the global employment industry. Through a robust technology roadmap and a focus on agentic AI solutions, G-P continuously enhances its products and platform to provide the most comprehensive and intelligent global employment solutions on the market.
“G-P is not just building global employment solutions for today, we’re pioneering technology that anticipates the needs of tomorrow’s HR and business leaders,” said Nat Natarajan, chief operating officer, G-P. “Our continued recognition from NelsonHall, and all other industry analysts, is a testament to our commitment to innovation. By integrating agentic AI at the core of our platform, we’re enabling organizations to scale globally with confidence, while helping shape a more connected and opportunity-rich world of work.”
For more information about G-P and its industry leadership, please visit us here.
About G-P
G-P (Globalization Partners) is the recognized leader in global employment, ranked No. 1 in every industry analyst report. G-P’s global employment platform delivers everything companies of all sizes need to manage the full employee lifecycle with its trusted Global HR Agent, G-P Gia™, and AI-powered Employer of Record (EOR) and Contractor products. G-P supports teams in 180+ countries with more than a decade of global employment experience, the largest team of in-country HR, legal, and compliance experts, and its unmatched proprietary knowledge base.
G-P: Global Made Possible™
To learn more, please visit: g-p.com or connect with us via LinkedIn, X, Facebook or check out our Blog.
About NelsonHall
NelsonHall is the leading global analyst firm dedicated to helping organizations understand the ‘art of the possible’ in digital operations transformation. With analysts in the U.S., Europe, and Asia Pacific, NelsonHall provides buy-side organizations with detailed, critical information on markets and vendors that helps them make fast and highly informed sourcing decisions. And for vendors, NelsonHall provides deep knowledge of market dynamics and user requirements to help them hone their go-to-market strategies. NelsonHall’s analysis is based on rigorous, primary research, and is widely respected for the quality and depth of its insight.
Media Contact:
comms@g-p.com



Đề xuất
Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter
Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026
Max Immunity Clinic Opens in Markham, Offering Regenerative and Recovery-Based Therapies
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region